FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997960077> ?p ?o ?g. }

• W2997960077 endingPage "668" @default.
• W2997960077 startingPage "661" @default.
• W2997960077 abstract "Background: Recent reports suggest that torasemide might be more beneficial than furosemide in patients with symptomatic heart failure (HF). The aim was to compare the effects of torasemide and furosemide on clinical outcomes in HF patients. Methods: This study pilot consisted of data from the ongoing multicenter, randomized, unblinded endpoint phase IV TORNADO (NCT01942109) study. HF patients in New York Heart Association (NYHA) II–IV class with a stable dose of furosemide were randomized to treatment with equipotential dose of torasemide (4:1) or continuation of unchanged dose of furosemide. On enrollment and control visit (3 months after enrollment) clinical examination, 6-minute walk test (6MWT) and assessment of fluid retention by ZOE Fluid Status Monitor were performed. The primary endpoint was a composite of improvement of NYHA class, improvement of at least 50 m during 6MWT and decrease in fluid retention of at least 0.5 W after 3-months follow-up. Results: The study group included 40 patients (median age 66 years; 77.5% male). During follow-up 7 patients were hospitalized for HF worsening (3 in torasemide and 4 in furosemide-treated patients). The primary endpoint reached 15 (94%) and 14 (58%) patients on torasemide and furosemide, respectively (p = 0.03). Conclusions: In HF patients treated with torasemide fluid overload and symptoms improved more than in the furosemide group. This positive effect occurred already within 3-month observation." @default.
• W2997960077 created "2020-01-10" @default.
• W2997960077 creator A5001709390 @default.
• W2997960077 creator A5005371696 @default.
• W2997960077 creator A5008130178 @default.
• W2997960077 creator A5009219513 @default.
• W2997960077 creator A5010987753 @default.
• W2997960077 creator A5019388183 @default.
• W2997960077 creator A5026657729 @default.
• W2997960077 creator A5031505195 @default.
• W2997960077 creator A5032469463 @default.
• W2997960077 creator A5032746599 @default.
• W2997960077 creator A5034046159 @default.
• W2997960077 creator A5035410804 @default.
• W2997960077 creator A5039684673 @default.
• W2997960077 creator A5041176470 @default.
• W2997960077 creator A5045815995 @default.
• W2997960077 creator A5046703561 @default.
• W2997960077 creator A5059132544 @default.
• W2997960077 creator A5070552408 @default.
• W2997960077 creator A5074734262 @default.
• W2997960077 creator A5079360411 @default.
• W2997960077 date "2020-01-22" @default.
• W2997960077 modified "2023-10-01" @default.
• W2997960077 title "Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial" @default.
• W2997960077 cites W1521394689 @default.
• W2997960077 cites W1852552079 @default.
• W2997960077 cites W191189789 @default.
• W2997960077 cites W1964350642 @default.
• W2997960077 cites W1992857605 @default.
• W2997960077 cites W2026968890 @default.
• W2997960077 cites W2040618276 @default.
• W2997960077 cites W2057108655 @default.
• W2997960077 cites W2059603849 @default.
• W2997960077 cites W2065350647 @default.
• W2997960077 cites W2079740085 @default.
• W2997960077 cites W2086793695 @default.
• W2997960077 cites W2091872000 @default.
• W2997960077 cites W2126778293 @default.
• W2997960077 cites W2168777122 @default.
• W2997960077 cites W2171686127 @default.
• W2997960077 cites W2215178271 @default.
• W2997960077 cites W2271356218 @default.
• W2997960077 cites W2412478742 @default.
• W2997960077 cites W2427094903 @default.
• W2997960077 cites W2580930669 @default.
• W2997960077 cites W2744293479 @default.
• W2997960077 cites W2912858852 @default.
• W2997960077 cites W2910430081 @default.
• W2997960077 doi "https://doi.org/10.5603/cj.a2019.0114" @default.
• W2997960077 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8083045" @default.
• W2997960077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31909470" @default.
• W2997960077 hasPublicationYear "2020" @default.
• W2997960077 type Work @default.
• W2997960077 sameAs 2997960077 @default.
• W2997960077 citedByCount "10" @default.
• W2997960077 countsByYear W29979600772022 @default.
• W2997960077 countsByYear W29979600772023 @default.
• W2997960077 crossrefType "journal-article" @default.
• W2997960077 hasAuthorship W2997960077A5001709390 @default.
• W2997960077 hasAuthorship W2997960077A5005371696 @default.
• W2997960077 hasAuthorship W2997960077A5008130178 @default.
• W2997960077 hasAuthorship W2997960077A5009219513 @default.
• W2997960077 hasAuthorship W2997960077A5010987753 @default.
• W2997960077 hasAuthorship W2997960077A5019388183 @default.
• W2997960077 hasAuthorship W2997960077A5026657729 @default.
• W2997960077 hasAuthorship W2997960077A5031505195 @default.
• W2997960077 hasAuthorship W2997960077A5032469463 @default.
• W2997960077 hasAuthorship W2997960077A5032746599 @default.
• W2997960077 hasAuthorship W2997960077A5034046159 @default.
• W2997960077 hasAuthorship W2997960077A5035410804 @default.
• W2997960077 hasAuthorship W2997960077A5039684673 @default.
• W2997960077 hasAuthorship W2997960077A5041176470 @default.
• W2997960077 hasAuthorship W2997960077A5045815995 @default.
• W2997960077 hasAuthorship W2997960077A5046703561 @default.
• W2997960077 hasAuthorship W2997960077A5059132544 @default.
• W2997960077 hasAuthorship W2997960077A5070552408 @default.
• W2997960077 hasAuthorship W2997960077A5074734262 @default.
• W2997960077 hasAuthorship W2997960077A5079360411 @default.
• W2997960077 hasBestOaLocation W29979600771 @default.
• W2997960077 hasConcept C126322002 @default.
• W2997960077 hasConcept C164705383 @default.
• W2997960077 hasConcept C168563851 @default.
• W2997960077 hasConcept C203092338 @default.
• W2997960077 hasConcept C2777955127 @default.
• W2997960077 hasConcept C2778198053 @default.
• W2997960077 hasConcept C2779918671 @default.
• W2997960077 hasConcept C71924100 @default.
• W2997960077 hasConceptScore W2997960077C126322002 @default.
• W2997960077 hasConceptScore W2997960077C164705383 @default.
• W2997960077 hasConceptScore W2997960077C168563851 @default.
• W2997960077 hasConceptScore W2997960077C203092338 @default.
• W2997960077 hasConceptScore W2997960077C2777955127 @default.
• W2997960077 hasConceptScore W2997960077C2778198053 @default.
• W2997960077 hasConceptScore W2997960077C2779918671 @default.
• W2997960077 hasConceptScore W2997960077C71924100 @default.
• W2997960077 hasIssue "6" @default.
• W2997960077 hasLocation W29979600771 @default.

• next